Dexamethasone implant in the management of diabetic macular edema from clinician’s perspective
Mojca Urbančič,1 Ivana Gardašević Topčić21Eye Hospital, University Medical Centre Ljubljana, Ljubljana, Slovenia; 2Department of Ophthalmology, General Hospital in Novo mesto, Ljubljana, SloveniaAbstract: The aim of this article is to provide an overview of characteristics and principles...
Saved in:
Main Authors: | Urbančič M, Gardašević Topčić I |
---|---|
Format: | article |
Language: | EN |
Published: |
Dove Medical Press
2019
|
Subjects: | |
Online Access: | https://doaj.org/article/bc8645a945cb41b0a370dbaa66ac1d85 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
A Real-World Study of Dexamethasone Implant in Treatment-Naïve Patients with Diabetic Macular Edema: Efficacy and Correlation Between Inflammatory Biomarkers and Treatment Outcome
by: Vadalà M, et al.
Published: (2020) -
Macular edema resolution assessment with implantable dexamethasone in diabetic retinopathy (MERIT): a pilot study
by: Chhablani J, et al.
Published: (2018) -
Impact of Different Clinical Baseline Characteristics on Intravitreal Dexamethasone Implant Ozurdex® Outcomes
by: Udaondo P, et al.
Published: (2021) -
Outcome of Single Dexamethasone Implant Injection in the Treatment of Persistent Diabetic Macular Edema After Anti-VEGF Treatment: Real-Life Data from a Tertiary Hospital in Jordan
by: Al-Latayfeh M, et al.
Published: (2021) -
Real-world retrospective comparison of 0.19 mg fluocinolone acetonide and 0.7 mg dexamethasone intravitreal implants for the treatment of diabetic macular edema in vitrectomized eyes
by: Coelho J, et al.
Published: (2019)